Ying Jiang
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Colorectal Cancer Screening and Detection
Papers in
-
- Metabolomics and Mass Spectrometry Studies 4
- Circular RNAs in diseases 4
- Ubiquitin and proteasome pathways 3
- Glycosylation and Glycoproteins Research 3
- Epigenetics and DNA Methylation 3
-
- Cancer, Lipids, and Metabolism 6
- Cancer-related molecular mechanisms research 4
- Co-authors
- Weiqi Lu (11 shared papers)Qiwen Ben (5 shared papers)Zehuan Li (8 shared papers)Hong Shen (2 shared papers)Zhanghan Chen (6 shared papers)Yong Zhang (6 shared papers)Wei An (2 shared papers)Yue Xiong (2 shared papers)
- Journals
- Oncotarget (3 papers)PLoS ONE (2 papers)Clinical Rheumatology (2 papers)Medicine (2 papers)Journal of Cancer Research and Clinical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ying Jiang
73 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 433
- Oncology 463
- Molecular Biology 900
- Geriatrics and Gerontology 31
- Cell Biology 154
Countries citing papers authored by Ying Jiang
This map shows the geographic impact of Ying Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Jiang more than expected).
Fields of papers citing papers by Ying Jiang
This network shows the impact of papers produced by Ying Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Jiang. The network helps show where Ying Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ying Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 272 | |
| 2 | 2011 | 163 | |
| 3 | 2012 | 161 | |
| 4 | 2012 | 135 | |
| 5 | 2018 | 113 | |
| 6 | 2011 | 95 | |
| 7 | 2008 | 83 | |
| 8 | Roles of circular RNA in breast cancer: present and future. | 2019 | 74 |
| 9 | 2013 | 60 | |
| 10 | 2017 | 50 | |
| 11 | 2013 | 47 | |
| 12 | 2016 | 44 | |
| 13 | 2017 | 38 | |
| 14 | 2020 | 35 | |
| 15 | CircMMP11 acts as a ce-circRNA in breast cancer progression by regulating miR-1204. | 2020 | 31 |
| 16 | 2019 | 31 | |
| 17 | 2016 | 30 | |
| 18 | 2015 | 29 | |
| 19 | 2009 | 28 | |
| 20 | 2024 | 26 |
About Ying Jiang
Ying Jiang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Surgery, having authored 78 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (6 papers), Advanced Proteomics Techniques and Applications (5 papers), Cancer-related molecular mechanisms research (4 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Circular RNAs in diseases (4 papers), Ubiquitin and proteasome pathways (3 papers), Glycosylation and Glycoproteins Research (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (433 citations), Oncology (463 citations), Molecular Biology (900 citations), Geriatrics and Gerontology (31 citations) and Cell Biology (154 citations). Ying Jiang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Weiqi Lu, Qiwen Ben, Zehuan Li, Hong Shen, Zhanghan Chen, Yong Zhang, Wei An, Yue Xiong, Kun‐Liang Guan and Qun‐Ying Lei. Their work appears in journals such as Oncotarget, PLoS ONE, Clinical Rheumatology, Medicine and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.